SCHEMBL7565254

SCHEMBL7565254

O=C(O)CCCC(=O)OCc1cccc2c1Cc1ccccc1-2.OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.40
PNMT P11086 1/20 0.40
HTR2C P28335 1/20 0.36
SLC6A3 Q01959 1/20 0.36
EPHX2 P34913 2/20 0.34
PTGER1 P34995 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGER3 P43115 1/20 0.34
PTGER2 P43116 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPT P10636 1/20 0.34
HSD17B10 Q99714 1/20 0.34
EGFR P00533 1/20 0.32
HTR7 P34969 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5497721 0.90 PNMT (0.48) PNMTPTGER1PTGER4PTGER3PTGER2
SCHEMBL5497718 0.85 PNMT (0.53) KMT2APNMTEPHX2NPC1RAB9A
SCHEMBL6849876 0.83 PNMT (0.50) PNMTPTGER1PTGER4PTGER3PTGER2
Methyl Alcohol SCHEMBL7565244 0.81 PNMT (0.41) KMT2APNMTHTR2CSLC6A3EPHX2
SCHEMBL7559894 0.80 PNMT (0.39) PNMTPTGER1PTGER4PTGER3PTGER2
SCHEMBL7565247 0.78 KMT2A (0.58) KMT2AEPHX2NPC1FFAR4EGFR
SCHEMBL4059193 0.78 PNMT (0.50) KMT2APNMTHTR2CPTGER1PTGER4
SCHEMBL4059189 0.77 PNMT (0.54) KMT2APNMTHTR2CNPC1RAB9A
SCHEMBL27429983 0.77 PNMT (0.52) PNMTEPHX2NPC1RAB9AALDH1A1
SCHEMBL1830397 0.77 PNMT (0.57) KMT2APNMTHTR2CPTGER1PTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1225918-A2 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER Merck & Co., Inc. (US) 2002-07-31 EP disclosed
WO-2001028593-A2 CONJUGATES USEFUL IN THE TREATMENT OF PROSTATE CANCER MERCK & CO., INC. (US) 2001-04-26 WO disclosed